[Study of Tulobuterol Patch] Diagnostic procedure for infantile bronchial asthma <Pilot Study> -Evaluation of Tulobuterol Patch using pulse oximetry
Phase 4
Recruiting
- Conditions
- infantile bronchial asthma
- Registration Number
- JPRN-UMIN000009904
- Lead Sponsor
- Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
i.Patients receiving an inhaled long-acting beta-2 agonist (inhaled salmeterol) or receiving an oral short-acting beta-2 agonist continuously. ii.Patients who have known hypersensitivity to Tulobuterol Patch or have a skin disease, including atopic dermatitis, and are considered inappropriate to use Tulobuterol Patch. iii.Patients who have thyroid hyperfunction disorders, hypertension, cardiac disorder, or diabetes concurrently, and are considered inappropriate to use a beta-2 antagonist. iv.Patients who have experienced serious adverse drug reactions of Tulobuterol. v.Patients who, in the opinion of the investigator are inappropriate for inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method